Incretins have used for treatment of Type2 DM and there are ongoing trials for their use in obesity. could they be used in patients with metabolic syndrome or would it actually be harmful in these patients , considering their mode of action involves raising insulin levels and inhibiting glucagon release.
Would you read this article by award winning journalist Whitney Webb (2019 winner of the Serena Shim Award for Uncompromising Integrity in Journalism)? Bob? Anyone? This is a problem worth having great minds think out loud about. Thank you for your very hard work and commitment to practicing excellence. https://unlimitedhangout.com/2021/05/investigative-reports/this-biden-proposal-could-make-the-us-a-digital-dictatorship/